ResMed Long Term Debt 2010-2023 | RMD

ResMed long term debt from 2010 to 2023. Long term debt can be defined as the sum of all long term debt fields.
  • ResMed long term debt for the quarter ending December 31, 2023 was $1.217B, a 32.05% decline year-over-year.
  • ResMed long term debt for 2023 was $1.431B, a 87.01% increase from 2022.
  • ResMed long term debt for 2022 was $0.765B, a 18.96% increase from 2021.
  • ResMed long term debt for 2021 was $0.643B, a 44.74% decline from 2020.
ResMed Annual Long Term Debt
(Millions of US $)
2023 $1,431
2022 $765
2021 $643
2020 $1,164
2019 $1,259
2018 $270
2017 $1,079
2016 $873
2015 $301
2014 $301
2013 $1
2012 $251
2011 $100
2010 $
2009 $94
ResMed Quarterly Long Term Debt
(Millions of US $)
2023-12-31 $1,217
2023-09-30 $1,352
2023-06-30 $1,431
2023-03-31 $1,576
2022-12-31 $1,791
2022-09-30 $785
2022-06-30 $765
2022-03-31 $669
2021-12-31 $668
2021-09-30 $794
2021-06-30 $643
2021-03-31 $719
2020-12-31 $814
2020-09-30 $1,044
2020-06-30 $1,164
2020-03-31 $1,365
2019-12-31 $1,288
2019-09-30 $1,208
2019-06-30 $1,259
2019-03-31 $1,323
2018-12-31 $1,186
2018-09-30 $518
2018-06-30 $270
2018-03-31 $810
2017-12-31
2017-09-30 $1,019
2017-06-30 $1,079
2017-03-31 $1,168
2016-12-31 $869
2016-09-30 $874
2016-06-30 $873
2016-03-31 $436
2015-12-31 $401
2015-09-30 $501
2015-06-30 $301
2015-03-31 $461
2014-12-31 $450
2014-09-30 $376
2014-06-30 $301
2014-03-31 $396
2013-12-31 $436
2013-09-30 $1
2013-06-30 $1
2013-03-31 $1
2012-12-31 $301
2012-09-30 $266
2012-06-30 $251
2012-03-31 $235
2011-12-31 $225
2011-09-30 $130
2011-06-30 $100
2011-03-31 $80
2010-12-31
2010-09-30
2010-06-30
2010-03-31 $29
2009-12-31 $95
2009-09-30 $95
2009-06-30 $94
2009-03-31 $93
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $26.124B $4.223B
ResMed, Inc. holds a major position as designer, manufacturer, as well as a distributor in the worldwide market for generators, masks, and related accessories for the treatment of sleep-disordered breathing (SDB) and other respiratory disorders. SDB includes obstructive sleep apnea (OSA) and other respiratory disorders that occur during sleep. The company currently has two operating segments, which are the Sleep and Respiratory Care segment and the Software-as-a-Service segment.
Stock Name Country Market Cap PE Ratio
Abbott Laboratories (ABT) United States $182.663B 23.98
Stryker (SYK) United States $124.585B 30.89
Medtronic (MDT) Ireland $105.150B 14.89
Boston Scientific (BSX) United States $98.912B 32.89
EssilorLuxottica (ESLOY) France $98.803B 0.00
Lonza Group Ag (LZAGY) Switzerland $41.442B 0.00
Haleon (HLN) United Kingdom $37.123B 29.04
Terumo (TRUMY) Japan $24.607B 34.75
Zimmer Biomet Holdings (ZBH) United States $24.518B 15.78
Baxter (BAX) United States $20.135B 14.69
Koninklijke Philips (PHG) Netherlands $18.554B 14.80
Insulet (PODD) United States $11.535B 60.56
Smith & Nephew SNATS (SNN) United Kingdom $10.496B 0.00
Demant (WILYY) Denmark $9.782B 0.00
Bio-Rad Laboratories (BIO) United States $8.014B 23.88
BellRing Brands (BRBR) United States $7.103B 38.19
Lantheus Holdings (LNTH) United States $4.273B 11.03
Haemonetics (HAE) United States $4.239B 21.68
Perrigo (PRGO) Ireland $4.057B 11.60
GN Store Nord (GNNDY) Denmark $3.581B 23.19
Envista Holdings (NVST) United States $3.394B 12.91
Prestige Consumer Healthcare (PBH) United States $3.394B 16.05
Green Thumb Industries (GTBIF) United States $2.720B 86.20
Neogen (NEOG) United States $2.584B 24.85
QuidelOrtho (QDEL) United States $2.559B 9.29
ICU Medical (ICUI) United States $2.361B 17.62
TG Therapeutics (TGTX) United States $2.160B 699.50
Maravai LifeSciences Holdings (MRVI) United States $1.913B 0.00
Owens & Minor (OMI) United States $1.843B 17.69
Verano Holdings (VRNOF) United States $1.841B 0.00
Agios Pharmaceuticals (AGIO) United States $1.654B 0.00
National Vision Holdings (EYE) United States $1.466B 45.66
InMode (INMD) Israel $1.456B 7.54
LeMaitre Vascular (LMAT) United States $1.406B 46.38
AdaptHealth (AHCO) United States $1.244B 9.36
Warby Parker (WRBY) United States $1.169B 0.00
AtriCure (ATRC) United States $1.131B 0.00
MacroGenics (MGNX) United States $1.005B 0.00
Cresco Labs (CRLBF) United States $0.726B 0.00
BioLife Solutions (BLFS) United States $0.718B 0.00
Canopy Growth (CGC) Canada $0.713B 0.00
VAREX IMAGING (VREX) United States $0.687B 14.84
Evolus (EOLS) United States $0.670B 0.00
Jin Medical (ZJYL) China $0.617B 0.00
Quanterix (QTRX) United States $0.604B 0.00
Valneva SE (VALN) France $0.565B 0.00
Phibro Animal Health (PAHC) United States $0.528B 11.44
TerrAscend (TSNDF) Canada $0.507B 0.00
PetIQ (PETQ) United States $0.472B 17.61
ZimVie (ZIMV) United States $0.427B 26.13
Biote (BTMD) United States $0.405B 3.86
OraSure Technologies (OSUR) United States $0.402B 6.65
Surmodics (SRDX) United States $0.376B 40.60
Zynex (ZYXI) United States $0.368B 42.41
Aurora Cannabis (ACB) Canada $0.356B 0.00
Viemed Healthcare (VMD) United States $0.302B 30.00
Cerus (CERS) United States $0.297B 0.00
Sanara MedTech (SMTI) United States $0.293B 0.00
TriSalus Life Sciences (TLSI) United States $0.259B 0.00
Utah Medical Products (UTMD) United States $0.241B 14.71
Veru (VERU) United States $0.208B 0.00
Organigram Holdings (OGI) Canada $0.193B 0.00
Ayr Wellness (AYRWF) United States $0.189B 0.00
Omeros (OMER) United States $0.186B 0.00
High Tide (HITI) Canada $0.175B 0.00
Capricor Therapeutics (CAPR) United States $0.159B 0.00
Quipt Home Medical (QIPT) United States $0.148B 0.00
FitLife Brands (FTLF) United States $0.134B 21.55
Jushi Holdings (JUSHF) United States $0.133B 0.00
Eagleford Energy (GRUSF) United States $0.131B 66.00
InterCure (INCR) Israel $0.118B 19.92
Fonar (FONR) United States $0.106B 9.14
MariMed (MRMD) United States $0.104B 0.00
Safety Shot (SHOT) United States $0.099B 0.00
Cellectar Biosciences (CLRB) United States $0.098B 0.00
Allurion Technologies (ALUR) United States $0.098B 0.00
Oramed Pharmaceuticals (ORMP) United States $0.089B 0.00
Chimerix (CMRX) United States $0.083B 0.00
Brainsway (BWAY) Israel $0.080B 0.00
Zevia PBC (ZVIA) United States $0.069B 0.00
Eagle Pharmaceuticals (EGRX) United States $0.058B 3.80
Apyx Medical (APYX) United States $0.048B 0.00
Cytosorbents (CTSO) United States $0.043B 0.00
Rockwell Medical (RMTI) United States $0.043B 0.00
Bright Green (BGXX) United States $0.042B 0.00
ImmuCell (ICCC) United States $0.039B 0.00
Modular Medical (MODD) United States $0.037B 0.00
United-Guardian (UG) United States $0.036B 14.04
Exagen (XGN) United States $0.025B 0.00
Nephros (NEPH) United States $0.021B 0.00
Agape ATP (ATPC) $0.018B 0.00
FSD PHARMA (HUGE) Canada $0.018B 0.00
Flora Growth (FLGC) United States $0.018B 0.00
GlucoTrack (GCTK) United States $0.018B 0.00
Meihua Medical Technologies (MHUA) China $0.016B 0.00
Trinity Biotech (TRIB) Ireland $0.014B 0.00
GUARDION HEALTH (GHSI) United States $0.010B 73.18
IM Cannabis (IMCC) Canada $0.008B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Leafly Holdings (LFLY) United States $0.005B 0.00
Sharps Technology (STSS) United States $0.005B 0.00
Senestech (SNES) United States $0.004B 0.00
Innovative Eyewear (LUCY) United States $0.003B 0.00
Lucy Scientific Discovery (LSDI) Canada $0.002B 0.00
Akanda (AKAN) United Kingdom $0.001B 0.00
Smart For Life (SMFL) United States $0.000B 0.00
Bruush Oral Care (BRSH) $0.000B 0.00
SNDL (SNDL) Canada $0.000B 0.00